Alzheimer’s diagnosis could be transformed by new GP blood test
- A landmark study in Scotland, known as BriDGe, is offering people suspected of having Alzheimer’s disease the opportunity to receive a blood test through their general practitioner.
- More than 50 GP surgeries across central and northern Scotland are participating in the initiative, led by Scottish Brain Sciences, aiming to refer up to 500 patients.
- The project seeks to accelerate diagnosis, empower GPs with more informed decision-making, and ensure earlier access to crucial support and treatments for patients.
- The study utilises specific blood tests, p-tau181 and p-tau217, developed by Roche Diagnostics, which can detect or rule out Alzheimer’s earlier and more accurately than existing methods.
- Experts highlight that earlier diagnosis can aid patients with lifestyle modifications, allow them to access support sooner, and facilitate future planning, potentially transforming Alzheimer’s diagnosis.
More bulletins